Effects of Hwangryungeehwang-tang Aqueous extracts on streptozotocin-induced diabetic rat
DJ Yu, GM Yoon, SB Kang - The Journal of Internal Korean …, 2011 - koreascience.kr
Objectives: The object of this study was to observe the effects of Hwangryungeehwang-tang
(HRGHT), which has traditionally been used in Korean medicine for treating diabetes, by …
(HRGHT), which has traditionally been used in Korean medicine for treating diabetes, by …
Rosuwastatyna w prewencji pierwotnej schorzeń układu sercowo-naczyniowego
Statyny należą do najczęściej stosowanych grup leków na świecie. Poza działaniem
hipolipemizującym wywierają wpływ na wiele działań pozalipidowych. Szczególnie …
hipolipemizującym wywierają wpływ na wiele działań pozalipidowych. Szczególnie …
[引用][C] Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia
MI Flores, CC SC
Effects of Chunglijagam-tang Aqueous Extracts on streptozotocin-induced rat diabetes and related complications
YS Park, GM Yoon, EY Im, HC Shin… - The Journal of Internal …, 2010 - koreascience.kr
Objective: The object of this study was to observe the effects of aqueous extracts of
Chunglijagam-tang (CLJGT), which has traditionally been used in Korean medicine for …
Chunglijagam-tang (CLJGT), which has traditionally been used in Korean medicine for …
Avancées récentes et perspectives dans le traitement des dyslipidémies athérogènes
FC Aubart, B Hansel, JS Hulot, P Lechat… - La Revue de médecine …, 2007 - Elsevier
Résumé Propos Au cours des 30 dernières années, de grandes avancées ont permis
d'identifier des facteurs de risque cardiovasculaire et mettre en place des mesures pour les …
d'identifier des facteurs de risque cardiovasculaire et mettre en place des mesures pour les …
Cardiovascular risk associated with antiretroviral therapy in HIV-infected patients
DL Calza, R Manfredi, F Chiodo - Expert Opinion on Therapeutic …, 2006 - Taylor & Francis
Cardiovascular risk factors, including the fat redistribution syndrome, dyslipidaemia, insulin
resistance and diabetes mellitus, have been increasingly described in association with new …
resistance and diabetes mellitus, have been increasingly described in association with new …
High-intensity therapy: rationale, indications and safety issues. Prospects of rosuvastatin in clinical practice
MG Bubnova - CardioSomatics, 2017 - cardiosomatics.orscience.ru
The review is devoted to the problem of high-intensity therapy. Evidence of the effectiveness
of statin prescribing in high-intensity mode is presented to patients with very high …
of statin prescribing in high-intensity mode is presented to patients with very high …
[PDF][PDF] PHARMACEUTICAL SYNTHETIC REVIEW OF ROSUVASTATIN CALCIUM
P Patil, DV Nagarale, BR Chaudhari - 2017 - wjpr.s3.ap-south-1.amazonaws.com
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and
related conditions, and to prevent cardiovascular disease. It was developed by Shionogi …
related conditions, and to prevent cardiovascular disease. It was developed by Shionogi …
[HTML][HTML] Высокоинтенсивная терапия: обоснование, показания и вопросы безопасности. Перспективы розувастатина в клинической практике
МГ Бубнова - CardioСоматика, 2017 - cyberleninka.ru
Представленный обзор посвящен проблеме высокоинтенсивной терапии.
Представлены доказательства эффективности назначения статинов в режиме …
Представлены доказательства эффективности назначения статинов в режиме …
[PDF][PDF] Research Journal of Pharmaceutical, Biological and Chemical Sciences
IBH Fat-Diet - researchgate.net
Hyperlipidemia is excessive amounts of fatty substance in the blood. In the present study,
the effects of silver nanoparticles and rosuvastatin on serum lipid profile in high cholesterol …
the effects of silver nanoparticles and rosuvastatin on serum lipid profile in high cholesterol …